DTAB agrees change of Allergan India Refresh Tears from prescription drug to OTC

Granting drug maker Allergan India request to change the category of "Refresh Tears" from prescription drug to over the counter drug, the Drug Technical Advisory Board (DTAB) has agreed to remove the requirement of a prescription from a Registered Medical Practitioner (RMP) in respect of drug product "Refresh Tears" (Carboxymethylcellulose Sodium eye drops IP 0.5% w/v) for its retail sale.

The recommendation was made after considering the proposal made by Allergan India to remove the requirement for a prescription in respect of drug product "Refresh Tears" (Carboxymethylcellulose Sodium eye drops IP 0.5% w/v) sterile opthalmic solution for retail sale.

The drug maker, Allergen, has submitted that its product "Refresh Tears" contains Carboxymethylcellulose Sodium eye drops 0.5% w/v, sterile ophthalmic solution, indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eyes or exposure to wind or sun, and may be used as a protectant against further irritation, and stated that the product has been marketed since 1998.

For more details check out the link given below:

No Need Of Prescription From Doctors For Refresh Tears: DTAB